This is an excellent ann, no wonder the ASX scrutinized it so heavily.
I am really glad Camargo will accompany us when meeting with the FDA, their expertise is invaluable.
My previous example to Tetra Biopharma and their ARDS-003 drug I think gives confidence to IHL's meeting with the FDA as ARDS-003 was granted a Pre-IND and ability to conduct Phase 1 human trials in COVID-19 patients. And their drug is just synthetic CBD, IHL-675A continues to outperform CBD immensely as can be seen by these In Vivo results.
Future looks bright!
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-9
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)